Correlation Between Tonix Pharmaceuticals and ROYALTY

Can any of the company-specific risk be diversified away by investing in both Tonix Pharmaceuticals and ROYALTY at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Tonix Pharmaceuticals and ROYALTY into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Tonix Pharmaceuticals Holding and ROYALTY PHARMA PLC, you can compare the effects of market volatilities on Tonix Pharmaceuticals and ROYALTY and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Tonix Pharmaceuticals with a short position of ROYALTY. Check out your portfolio center. Please also check ongoing floating volatility patterns of Tonix Pharmaceuticals and ROYALTY.

Diversification Opportunities for Tonix Pharmaceuticals and ROYALTY

-0.22

Correlation Coefficient

Tonix Pharmaceuticals  ROYALTY

Very good diversification

The 3 months correlation between Tonix and ROYALTY is -0.22. Overlapping area represents the amount of risk that can be diversified away by holding Tonix Pharmaceuticals Holding and ROYALTY PHARMA PLC in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on ROYALTY PHARMA PLC and Tonix Pharmaceuticals is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Tonix Pharmaceuticals Holding are associated (or correlated) with ROYALTY. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of ROYALTY PHARMA PLC has no effect on the direction of Tonix Pharmaceuticals i.e., Tonix Pharmaceuticals and ROYALTY go up and down completely randomly.

Pair Corralation between Tonix Pharmaceuticals and ROYALTY

Given the investment horizon of 90 days Tonix Pharmaceuticals Holding is expected to under-perform the ROYALTY. In addition to that, Tonix Pharmaceuticals is 5.53 times more volatile than ROYALTY PHARMA PLC. It trades about -0.05 of its total potential returns per unit of risk. ROYALTY PHARMA PLC is currently generating about -0.28 per unit of volatility. If you would invest  8,468  in ROYALTY PHARMA PLC on October 25, 2024 and sell it today you would lose (831.00) from holding ROYALTY PHARMA PLC or give up 9.81% of portfolio value over 90 days.

Time Period	3 Months [change]
Direction	Moves Against
Strength	Insignificant
Accuracy	95.0%
Values	Daily Returns

Tonix Pharmaceuticals Holding  vs.  ROYALTY PHARMA PLC

Tonix Pharmaceuticals

Risk-Adjusted Performance

10 of 100

OK

Compared to the overall equity markets, risk-adjusted returns on investments in Tonix Pharmaceuticals Holding are ranked lower than 10 (%) of all global equities and portfolios over the last 90 days. Even with relatively unfluctuating basic indicators, Tonix Pharmaceuticals reported solid returns over the last few months and may actually be approaching a breakup point.

ROYALTY PHARMA PLC

Risk-Adjusted Performance

0 of 100

Very Weak

Over the last 90 days ROYALTY PHARMA PLC has generated negative risk-adjusted returns adding no value to investors with long positions. Despite latest fragile performance, the Bond's basic indicators remain strong and the current disturbance on Wall Street may also be a sign of long term gains for ROYALTY PHARMA PLC investors.

Pair Trading with Tonix Pharmaceuticals and ROYALTY

The main advantage of trading using opposite Tonix Pharmaceuticals and ROYALTY positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Tonix Pharmaceuticals position performs unexpectedly, ROYALTY can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in ROYALTY will offset losses from the drop in ROYALTY's long position.

The idea behind Tonix Pharmaceuticals Holding and ROYALTY PHARMA PLC pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio File Import module to quickly import all of your third-party portfolios from your local drive in csv format.